hyperplasia of mammary glands
Conditions
Interventions
Treatment group:ointment bilateral breast
Control group:Placebo
Sponsors
The Third affiliated Hospital of Beijing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: 1. with breast hyperplasia disease diagnosis standard; 2. at the age of 18 ~ 50 years old women ( including 18 and 50 years old), basic rules of the menstrual cycle and period. Menstrual cycle for 28 days - 7 days; 3. in group VAS>3 patients, pain of moderate pain; 4. previous cyclic premenstrual breast pain symptoms, course lasts for more than 3 months; 5. did not receive the treatment of hyperplasia of mammary glands, within six months not using hormonal preparations; 6. breast skin intact, no damage, no skin disease; 7. informed consent, voluntary subjects and signed informed consent.
Exclusion criteria
Exclusion criteria: 1. with breast hyperplasia disease diagnostic criteria, but does not have the cyclical breast pain; 2. associated with malignant breast tumor, inflammatory disorders and other endocrine diseases; 3. the menstrual cycle or period serious irregular; 4. with cardiovascular, hepatic, renal, hematopoietic system of severe primary disease, or psychiatric patients; 5. during pregnancy, lactation, menopause and preparation of pregnant women; 6. allergic constitution or known to the medicine component or allergy; 7. taking parting in other clinical drug trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Breast pain;Breast tumor size;Routine blood test;Urine routine test; | — |
Secondary
| Measure | Time frame |
|---|---|
| Curative effect of disease;TCM Comprehensive Treatment;Estradiol;Progesterone;Prolactin;quality of life; | — |
Countries
China
Contacts
Public ContactPei Xiaohua
Outcome results
None listed